StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)

Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%

Cvs Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cvs Health's operating income for the twelve months ending Jun 30, 2026 was $8.29B, down 7.4% year over year. For fiscal 2025 it was $4.66B, down 45.3% from the year before. Over ten years it grew -6.9% a year on average. The highest annual figure on record is $13.91B in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.66B-45.3%
FY2024Dec 31, 2024$8.52B-38.0%
FY2023Dec 31, 2023$13.74B+72.8%
FY2022Dec 31, 2022$7.95B-40.2%
FY2021Dec 31, 2021$13.31B-4.3%
FY2020Dec 31, 2020$13.91B+16.1%
FY2019Dec 31, 2019$11.99B+198.1%
FY2018Dec 31, 2018$4.02B-57.8%
FY2017Dec 31, 2017$9.54B-8.2%
FY2016Dec 31, 2016$10.39B+9.6%
FY2015Dec 31, 2015$9.48B+7.7%
FY2014Dec 31, 2014$8.80B+9.5%
FY2013Dec 31, 2013$8.04B+11.5%
FY2012Dec 31, 2012$7.21B+13.9%
FY2011Dec 31, 2011$6.33B+3.2%
FY2010Dec 31, 2010$6.14B-4.5%
FY2009Dec 31, 2009$6.43B+6.3%
FY2008Dec 31, 2008$6.05B+26.1%
FY2007Dec 29, 2007$4.79B–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.70B+97.5%
Q1 FY2026Mar 31, 2026$4.68B+38.7%
Q4 FY2025Dec 31, 2025$2.11B-10.8%
Q3 FY2025Sep 30, 2025-$3.21B-485.5%
Q2 FY2025Jun 30, 2025$2.38B-21.8%
Q1 FY2025Mar 31, 2025$3.37B+48.6%
Q4 FY2024Dec 31, 2024$2.37B-29.8%
Q3 FY2024Sep 30, 2024$832.00M-77.5%
Q2 FY2024Jun 30, 2024$3.05B-5.8%
Q1 FY2024Mar 31, 2024$2.27B-34.1%
Q4 FY2023Dec 31, 2023$3.37B-7.8%
Q3 FY2023Sep 30, 2023$3.69B–
Q2 FY2023Jun 30, 2023$3.23B-30.7%
Q1 FY2023Mar 31, 2023$3.45B-2.8%
Q4 FY2022Dec 31, 2022$3.66B+56.0%
Q3 FY2022Sep 30, 2022-$3.92B-228.0%
Q2 FY2022Jun 30, 2022$4.67B+7.9%
Q1 FY2022Mar 31, 2022$3.55B-0.9%
Q4 FY2021Dec 31, 2021$2.35B-7.1%
Q3 FY2021Sep 30, 2021$3.06B-5.8%
Q2 FY2021Jun 30, 2021$4.33B-7.6%
Q1 FY2021Mar 31, 2021$3.58B+3.4%
Q4 FY2020Dec 31, 2020$2.52B-16.9%
Q3 FY2020Sep 30, 2020$3.25B+11.0%
Q2 FY2020Jun 30, 2020$4.68B+40.5%
Q1 FY2020Mar 31, 2020$3.46B+28.6%
Q4 FY2019Dec 31, 2019$3.04B+268.6%
Q3 FY2019Sep 30, 2019$2.93B+13.8%
Q2 FY2019Jun 30, 2019$3.33B–
Q1 FY2019Mar 31, 2019$2.69B+34.8%
Q4 FY2018Dec 31, 2018$824.00M-73.5%
Q3 FY2018Sep 30, 2018$2.57B+2.8%
Q2 FY2018Jun 30, 2018-$1.37B-164.7%
Q1 FY2018Mar 31, 2018$2.00B+11.0%
Q4 FY2017Dec 31, 2017$3.11B+3.8%
Q3 FY2017Sep 30, 2017$2.50B-11.3%
Q2 FY2017Jun 30, 2017$2.12B–
Q1 FY2017Mar 31, 2017$1.80B–
Q4 FY2016Dec 31, 2016$3.00B–
Q3 FY2016Sep 30, 2016$2.82B–

More Cvs Health figures

See a number that looks wrong?